Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
S. Gandi (Edinburgh, United Kingdom), I. Cranston (Edinburgh, United Kingdom), G. Mclachlan (Edinburgh, United Kingdom), S. Wright (Edinburgh, United Kingdom), J. Baily (Edinburgh, United Kingdom), S. Stimpson (Saffron Walden, United Kingdom), S. Madden (Edinburgh, United Kingdom), M. Whitmarsh (Harlow, United Kingdom), A. Young (Harlow, United Kingdom), M. Mcelroy (Edinburgh, United Kingdom)
Source: International Congress 2018 – Mechanisms of respiratory infection
Session: Mechanisms of respiratory infection
Session type: Thematic Poster
Number: 2656
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Gandi (Edinburgh, United Kingdom), I. Cranston (Edinburgh, United Kingdom), G. Mclachlan (Edinburgh, United Kingdom), S. Wright (Edinburgh, United Kingdom), J. Baily (Edinburgh, United Kingdom), S. Stimpson (Saffron Walden, United Kingdom), S. Madden (Edinburgh, United Kingdom), M. Whitmarsh (Harlow, United Kingdom), A. Young (Harlow, United Kingdom), M. Mcelroy (Edinburgh, United Kingdom). Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73. 2656
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: